Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Comment by CancerSlayeron Jun 16, 2022 3:08pm
197 Views
Post# 34762328

RE:Core One mgmt, get on with it

RE:Core One mgmt, get on with it

 

Is COOL's synthetic product even scalable?  And could they even get friendly financing to scale it up?  What happened to generating revs from their Cannastrip machine?  I think they are no more than a micro R&D company in a very small & highly regulated/non-commercial niche that is just hoping for a big payday/buyout.  The only problem is...their is no serious/legitimate Pharma player (outside of another cannabis/nutraceutical co.) that would be willing to even negotiate, let alone pay the right price for the owners of COOL.  Now that financials have been delayed again, confidence must be at an all time low.  JMHO.

<< Previous
Bullboard Posts
Next >>